Trials / Conditions / NSCLC Adenocarcinoma
NSCLC Adenocarcinoma
6 registered clinical trials studyying NSCLC Adenocarcinoma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413 | IDEAYA Biosciences | Phase 1 |
| Not Yet Recruiting | Atamparib in Patients With Advanced Solid Tumors NCT07374419 | Nerviano Medical Sciences (Shanghai) Ltd. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer NCT06951399 | Rabin Medical Center | Phase 2 |
| Recruiting | A Study of MGC028 in Participants With Advanced Solid Tumors NCT06723236 | MacroGenics | Phase 1 |
| Active Not Recruiting | Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors NCT03252938 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Phase 1 |
| Terminated | Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Asse NCT02121899 | Myriad Genetic Laboratories, Inc. | — |